Evaluation of Risk Factors for Diabetic Peripheral Neuropathy Among Saudi Type 2 Diabetic Patients with Longer Duration of Diabetes

References

• International Diabetes Federation. Diabetes. Available from: https://idf.org/aboutdiabetes/what-is-diabetes.html. Accessed March 24, 2021.
   Google Scholar
• Al-Rubeaan K, Al-Manaa HA, Khoja TA, et al. Epidemiology of abnormal glucose metabolism in a country facing its epidemic: Saudi-DM study. J Diabetes. 2015;7:622–632. doi:10.1111/1753-0407.12224
   Web of Science ®Google Scholar
• Singh S. The genetics of type 2 diabetes mellitus: a review. JSR. 2011;55:35–48.
   Google Scholar
• Wolfs MG, Hofker M. Type 2 Diabetes Mellitus: new genetic insights will lead to new therapeutics. Curr Genomics. 2009;10:110–118. doi:10.2174/138920209787847023
   PubMed Web of Science ®Google Scholar
• Alhyas L, McKay A, Balasanthiran A, Majeed A. Prevalence of overweight, obesity, hyperglycaemia, hypertension and dyslipidaemia in the Gulf: systematic review. JRSMed Short Rep. 2011;2:55.
   PubMedGoogle Scholar
• Dyck PJ, Kratz KM, Karnes JL, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology. 1993;43:817–824. doi:10.1212/wnl.43.4.817
   PubMed Web of Science ®Google Scholar
• Young MJ, Boulton AJ, MacLeod AF, Williams DR, Sonksen PH. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia. 1993;36:150–154. doi:10.1007/BF00400697
   PubMed Web of Science ®Google Scholar
• Pirart J. Diabetes mellitus and its degenerative complications: a prospective study of 4400 patients observed between 1947 and 1973 (author’s translation). Diabeta Metab. 1977;3:245–256.
   PubMed Web of Science ®Google Scholar
• Kumar S, Ashe HA, Parnell LN. The prevalence of foot ulceration and its correlates in type 2 diabetic patients: a population-based study. Diabet Med. 1994;11(5):480–484. doi:10.1111/j.1464-5491.1994.tb00310.x.
   PubMed Web of Science ®Google Scholar
• Cabezas-Cerrato J. The prevalence of clinical diabetic polyneuropathy in Spain: a study in primary care and hospital clinic groups. Neuropathy Spanish Study Group of the Spanish Diabetes Society (SDS). Diabetologia. 1998;41(11):1263–1269. doi:10.1007/s001250051063
   Web of Science ®Google Scholar
• Boulton AJ, Malik RA, Arezzo JC, Sosenko JM. Diabetic somatic neuropathies. Diabetes Care. 2004;27:1458–1486. doi:10.2337/diacare.27.6.1458
   PubMed Web of Science ®Google Scholar
• Oh TJ, Lee J-E, Choi SH, Jang HC. Association between Body Fat and Diabetic Peripheral Neuropathy in Middle-Aged Adults with Type 2 Diabetes Mellitus: a Preliminary Report. J Obes Metab Syndr. 2019;28(2):112–117. doi:10.7570/jomes.2019.28.2.112
   PubMed Web of Science ®Google Scholar
• Schram MT, Chaturvedi N, Schalkwijk C, et al.; EURODIAB Prospective Complications Study. Vascular risk factors and markers of endothelial function as determinants of inflammatory markers in type 1 diabetes; The EURODIAB prospective complications study. Diabet Care. 2003;26:2165–2173. doi:10.2337/diacare.26.7.2165
   PubMed Web of Science ®Google Scholar
• Pinzur M, Freeland R, Juknelis D. The association between body mass index and foot disorders in diabetic patients. Foot Ankle Int. 2005;26:375–377. doi:10.1177/107110070502600506
   PubMed Web of Science ®Google Scholar
• Hashem HA, Mahfouz HM, Seddeek MI, Solaiman AM. Predictors of neuropathy in type 2 Egyptian diabetics. AAMJ. 2015;13(2):548.
   Google Scholar
• Li L, Chenb J, Wanga J, Caia D. Prevalence and risk factors of diabetic peripheral neuropathy in Type 2 diabetes mellitus patients with overweight /obese in Guangdong province, China. Prim Care Diabetes. 2013;9:191–195. doi:10.1016/j.pcd.2014.07.006
   Web of Science ®Google Scholar
• Tesfaye S, Stevens LK, Stephenson JM, et al. Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the Eurodiab IDDM complications study. Diabetologia. 1996;39:1377–1384. doi:10.1007/s001250050586
   PubMed Web of Science ®Google Scholar
• Al-Mahroos F, Al-Roomi K. Diabetic neuropathy, foot ulceration, peripheral vascular disease and potential risk factors among patients with diabetes in Bahrain: a nationwide primary care diabetes clinic-based study. Ann Saudi Med. 2007;27:25–31. doi:10.5144/0256-4947.2007.25
   PubMed Web of Science ®Google Scholar
• Al-Maskari F, El-Sadig M. Prevalence of risk factors for diabetic foot complications. BMC Fam Pract. 2007;8:59. doi:10.1186/1471-2296-8-59
   Web of Science ®Google Scholar
• Saadi H, Carruthers SG, Nagelkerke N, et al. Prevalence of diabetes mellitus and its complications in a population-based sample in Al Ain, United Arab Emirates. Diabetes Res ClinPract. 2007;78:369–377. doi:10.1016/j.diabres.2007.04.008
   PubMed Web of Science ®Google Scholar
• Al-Gefari M. Comparison of different screening tests for diagnosis of diabetic peripheral neuropathy in Primary Health Care setting. Int J Health Sci. 2012;6:127–134. doi:10.12816/0005988
   Google Scholar
• Kamel SR, Hamdy M, Abo Omar HAS, et al. Clinical diagnosis of distal diabetic polyneuropathy using neurological examination scores: correlation with nerve conduction studies. Egypt Rheumatol Rehabil. 2015;42:128–136. doi:10.4103/1110-161X.163945
   Google Scholar
• Pop-Busui R, Boulton AJM, Feldman EL, et al. Diabetic neuropathy: a position statement by the American Diabetes Association. Diabetes Care. 2017;40:136–154. doi:10.2337/dc16-2042
   PubMed Web of Science ®Google Scholar
• Freeman R. Not all neuropathy in diabetes is of diabetic etiology: differential diagnosis of diabetic neuropathy. Curr Diab Rep. 2009;9:423–431. doi:10.1007/s11892-009-0069-7
   Web of Science ®Google Scholar
• World Health Organization. Body mass index – BMI. Available from: https://www.euro.who.int/en/health-topics/disease-prevention/nutrition/a-healthy-lifestyle/body-mass-index-bmi. Accessed January 24, 2021.
   Google Scholar
• American Diabetes Association. 6 Glycemic Targets: standards of Medical Care in Diabetes-2021. Diabetes Care. 2021;44(Suppl 1):S73–S84. doi:10.2337/dc21-S006
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. 10. Cardiovascular Disease and Risk Management: standards of Medical Care in Diabetes—2021. Diabetes Care. 2021;44(Supplement 1):S125–S150. doi:10.2337/dc21-S010
   PubMed Web of Science ®Google Scholar
• Khawaja N, Abu-Shennar J, Saleh M, Dahbour SS, Khader YS, Ajlouni KM. The prevalence and risk factors of peripheral neuropathy among patients with type 2 diabetes mellitus; The case of Jordan. Diabetol Metab Syndr. 2018;10:8. doi:10.1186/s13098-018-0309-6
   PubMed Web of Science ®Google Scholar
• Tabatabaei-Malazy O, Mohajeri-Tehrani MR, Madani SP, Heshmat R, Larijani B. The prevalence of diabetic peripheral neuropathy and related factors. Iran J Public Health. 2011;40:55–62. doi:10.1097/qad.0b013e328345889d.
   Web of Science ®Google Scholar
• Al-Kaabi JM, Al-Maskari F, Zoubeidi T, et al. Prevalence and determinants of peripheral neuropathy in patients with type 2 diabetes attending a tertiary care center in the United Arab Emirates. J Diabetes Metab. 2014;5:346–353. doi:10.4172/2155-6156.1000346
   Google Scholar
• Bansal D, Gudala K, Muthyala H, Esam HP, Nayakallu R, Bhansali A. Prevalence and risk factors of development of peripheral diabetic neuropathy in type 2 diabetes mellitus in a tertiary care setting. J Diabetes Investig. 2014;5(6):714–721. doi:10.1111/jdi.12223
   PubMed Web of Science ®Google Scholar
• Liu F, Bao Y, Hu R, et al. Screening and prevalence of peripheral neuropathy in type 2 diabetic outpatients: a randomized multicenter survey in 12 city hospitals of China. Diabetes Metab Res Rev. 2010;26:481–489. doi:10.1002/dmrr.1107
   PubMed Web of Science ®Google Scholar
• Pop-Busui R, Lu J, Lopes N, Jones TL. Prevalence of diabetic peripheral neuropathy and relation to glycemic control therapies at baseline in the Bari 2D Cohort. J Peripher Nerv Syst. 2009;14:1–3. doi:10.1111/j.1529-8027.2009.00200
   Web of Science ®Google Scholar
• Callaghan B, Feldman E. The metabolic syndrome and neuropathy: therapeutic challenges and opportunities. Ann Neurol. 2013;74(3):397–403. doi:10.1002/ana.23986
   PubMed Web of Science ®Google Scholar
• Smith AG, Singleton JR. Obesity and hyperlipidemia are risk factors for early diabetic neuropathy. J Diabetes Complications. 2013;27(5):436–442. doi:10.1016/j.jdiacomp.2013.04.003
   PubMed Web of Science ®Google Scholar
• Booya F, Bandarian F, Larijani B, Pajouhi M, Noorae IM, Lotf J. Potential risk factors for diabetic neuropathy: a case control study. BMC Neurol. 2005;5:24–28. doi:10.1186/1471-2377-5-24
   PubMed Web of Science ®Google Scholar
• Katulanda P, Ranasinghe P, Jayawardena R, Constantine GR, Sheriff MH, Matthews DR. The prevalence, patterns and predictors of diabetic peripheral neuropathy in a developing country. Diabetol Metab Syndr. 2012;4:21. doi:10.1186/1758-5996-4-21
   Web of Science ®Google Scholar
• Won JC, Kwon HS, Kim CH, et al. Prevalence and clinical characteristics of diabetic peripheral neuropathy in hospital patients with type 2 diabetes in Korea. Diabet Med. 2012;29:e290–6. doi:10.1111/j.1464-5491.2012.03697.x
   Web of Science ®Google Scholar
• Jende JME, Groener JB, Rother C, et al. Association of serum cholesterol levels with peripheral nerve damage in patients with type 2 diabetes. JAMA Netw Open. 2019;2(5):e194798. doi:10.1001/jamanetworkopen.2019.4798
   PubMed Web of Science ®Google Scholar
• Börü UT, Alp R, Sargin H, et al. Prevalence of peripheral neuropathy in type 2 diabetic patients attending a diabetes center in Turkey. Endocr J. 2004;51(6):563–567. doi:10.1507/endocrj.51.563
   Web of Science ®Google Scholar
• Gogia S, Rao CR. Prevalence and risk factors for peripheral neuropathy among type 2 diabetes mellitus patients at a tertiary care hospital in coastal Karnataka. Indian J Endocrinol Metab. 2017;21(5):665–669. doi:10.4103/ijem.IJEM_43_17
   Google Scholar
• Bansal D, Gudala K, Muthyala H, Esam HP, Nayakallu R, Bhansali A. Prevalence and risk factors of development of peripheral diabetic neuropathy in type 2 diabetes mellitus in a tertiary care setting. J Diabetes Investig. 2014;5:714–721. doi:10.1111/jdi.12223
   PubMed Web of Science ®Google Scholar
• Pawde PP, Thampi RR, Renish RK, Resmi RU, Vivek MR. Prevalence and risk factors of diabetic peripheral neuropathy among type-2 diabetic patients presenting to SMIMS hospital, Tamil Nadu. Int J Med Sci Public Health. 2013;2:73–76. doi:10.5455/ijmsph.2013.2.73-76
   Google Scholar
• Booya F, Bandarian F, Larijani B, Pajouhi M, Nooraei M, Lotfi J. Potential risk factors for diabetic neuropathy: a case control study. BMC Neurol. 2005;5:24. doi:10.1186/1471-2377-5-24
   PubMed Web of Science ®Google Scholar
• Dutta A, Naorem S, Singh TP, Wangjam K. Prevalence of peripheral neuropathy in newly diagnosed type 2 diabetics. Int J Diabetes Dev Ctries. 2005;25:30–33. doi:10.4103/0973-3930.26756
   Google Scholar
• Mørkrid K, Ali L, Hussain A. Risk factors and prevalence of diabetic peripheral neuropathy: a study of type 2 diabetic outpatients in Bangladesh. Int J Diabetes Dev Ctries. 2010;30:11–17. doi:10.4103/0973-3930.60004
   Web of Science ®Google Scholar
• Pai YW, Lin CH, Lee IT, Chang MH. Variability of fasting plasma glucose and the risk of painful diabetic peripheral neuropathy in patients with type 2 diabetes. Diabetes Metab. 2018;44(2):129–134. doi:10.1016/j.diabet.2018.01.015
   PubMed Web of Science ®Google Scholar
• Yang CP, Li CI, Liu CS, et al. Variability of fasting plasma glucose increased risks of diabetic polyneuropathy in T2DM. Neurology. 2017;88(10):944–951. doi:10.1212/WNL.0000000000003682
   PubMed Web of Science ®Google Scholar
• Su JB, Zhao LH, Zhang XL, et al. HbA1c variability and diabetic peripheral neuropathy in type 2 diabetic patients. Cardiovasc Diabetol. 2018;17(1):47. doi:10.1186/s12933-018-0693-0
   PubMed Web of Science ®Google Scholar
• Aleidan FAS, Ahmad BA, Alotaibi FA, et al. Prevalence and Risk Factors for Diabetic Peripheral Neuropathy Among Saudi Hospitalized Diabetic Patients: a Nested Case-Control Study. Int J Gen Med. 2020;13:881–889. doi:10.2147/IJGM.S273807
   Web of Science ®Google Scholar
• Nie C, Bao HP. [Analysis of the related risk factors of diabetic peripheral neuropathy]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2012;26(6):467–469. Chinese.
   Google Scholar
• Rani PK, Raman R, Rachapalli SR, Pal SS, Kulothungan V, Sharma T. Prevalence and risk factors for severity of diabetic neuropathy in type 2 diabetes mellitus. Indian J Med Sci. 2010;64(2):51–57. doi:10.4103/0019-5359.94400
   PubMedGoogle Scholar
• Yang CP, Lin CC, Li CI, et al. Cardiovascular risk factors increase the risks of diabetic peripheral neuropathy in patients with type 2 diabetes mellitus: the Taiwan diabetes study. Medicine. 2015;94(42):e1783.
   Web of Science ®Google Scholar
• Kiani J, Moghimbeigi A, Azizkhani H, Kosarifard S. The prevalence and associated risk factors of peripheral diabetic neuropathy in Hamedan, Iran. Arch Iran Med. 2013;16(1):17–19.
   Web of Science ®Google Scholar